Technology

DyeVert™ PLUS EZ:

Proven Contrast Reduction with Uncompromised Imaging

DyeVert™ PLUS:

Proven Contrast Reduction with Uncompromised Imaging

DyeVert™ PLUS EZ Contrast Reduction System is a dye management solution for patients with at-risk kidney factors, including:

Moderate and severe chronic kidney disease

Diabetes

Older age

Heart failure

Dye reduction

DyeVert™ PLUS EZ is the only FDA cleared product with the claim of reduced dye delivery to the patient without impacting image quality.

Proven results

DyeVert™ PLUS EZ clinical results show over 40% average reduction in contrast dosage injected to the patient.¹

Real-time dose monitoring

DyeVert™ PLUS EZ module, smart-syringe and monitor wirelessly communicate real-time contrast monitoring throughout each procedure.

¹ Desch, S. et all. Impact of a novel contrast reduction system on contrast savings in coronary angiography – The DyeVert randomized controlled trial. Int J Cardiol (2018) https://doi.org/10.1016/j.ijcard.2017.12.107

Indications, contraindications, warnings, and instructions for use can be found in the product labeling supplied with each device. Risks may include air emboli and infection.
CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician.

Uncompromised Imaging: Seeing is Believing

Injections into coronary arteries may result in excess reflux into the aorta that is not needed for imaging. DyeVert™ PLUS EZ reduces contrast amount without compromising image quality. See for yourself.

Without contrast reduction

Contrast reflux leads to increased, unnecessary volume usage

With DyeVert™ PLUS EZ contrast reduction

reduced contrast reflux leads to decreased volume usage

Real-Time Monitoring

Optimizing procedures for coronary angiography patients at-risk for kidney injury starts with DyeVert™ PLUS EZ technology.

Learn more

The DyeVert™ PLUS EZ Technology

DyeVert™ PLUS EZ contrast reduction system is easy to use and incorporate into common cath-lab procedures.

See how it works